Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03 on Revenues of $11.6M
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03. Revenue for the quarter came in at $11.6 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
